New medical treatments haven’t reached everyone equally. Why? A lack of diversity in clinical trials. African Americans make up 13% of the US population but only 5% of clinical trial participants. Similarly, Hispanics are vastly underrepresented, comprising 15% of the population but just 1% of trial participants. (1) This disparity has real-world consequences. Treatments… Continue reading Why Diversity in Clinical Trials Matters
Why Diversity in Clinical Trials Matters
